Uterine myomas revisited

被引:45
作者
Duhan, Nirmala [1 ]
Sirohiwal, Daya [1 ]
机构
[1] Pt BD Sharma PGIMS, Dept Obstet & Gynecol, Rohtak 124001, Haryana, India
关键词
Uterine myomas; Development; Management; FOCUSED ULTRASOUND; ABDOMINAL MYOMECTOMY; ARTERY EMBOLIZATION; HYSTERECTOMY; LEIOMYOMAS; OUTCOMES; SURGERY;
D O I
10.1016/j.ejogrb.2010.05.010
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The present study was planned to review the pathophysiology of uterine myomas and emphasize the principles of logical management on the basis of literature review and synthesis of the author's experience. The growth of uterine myomas, the most common solid pelvic tumors in women, is related to genetic predisposition, hormonal influences and growth factors. The treatment options include pharmacologic, surgical and radiographic interventions. Most asymptomatic myomas can be followed serially for progressive growth or development of symptoms. The various diagnostic and therapeutic advancements available today permit higher management flexibility with safe options, which must be tailored to the individual patients requirement. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:119 / 125
页数:7
相关论文
共 33 条
[1]   Reproductive outcome before and after laparoscopic or abdominal myomectomy for subserous or intramural myomas [J].
Campo, S ;
Campo, V ;
Gambadauro, P .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2003, 110 (02) :215-219
[2]   Role of vaginal sonography and hysterosonography in the endoscopic treatment of uterine myomas [J].
Cohen, LS ;
Valle, RF .
FERTILITY AND STERILITY, 2000, 73 (02) :197-204
[3]   Interventional magnetic resonance imaging cryotherapy of uterine fibroid tumors: Preliminary observation [J].
Cowan, BD ;
Sewell, PE ;
Howard, JC ;
Arriola, RM ;
Robinette, LG .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2002, 186 (06) :1183-1187
[4]  
Crosignani PG, 1996, J REPROD MED, V41, P415
[5]   Leiomyoma pseudocapsule after pre-surgical treatment with gonadotropin-releasing hormone agonists: Relationship between clinical features and immunohistochemical changes [J].
De Falco, Marianna ;
Staibano, Stefania ;
Mascolo, Massimo ;
Mignogna, Chiara ;
Improda, Luigi ;
Ciociola, Francesca ;
Carbone, Ilma F. ;
Di Lieto, Andrea .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2009, 144 (01) :44-47
[6]   Danazol administration after gonadotrophin-releasing hormone analogue reduces rebound of uterine myomas [J].
DeLeo, V ;
Morgante, G ;
Lanzetta, D ;
DAntona, D ;
Bertieri, RS .
HUMAN REPRODUCTION, 1997, 12 (02) :357-360
[7]   What are the implications of myomas on fertility? A need for a debate? [J].
Donnez, J ;
Jadoul, P .
HUMAN REPRODUCTION, 2002, 17 (06) :1424-1430
[8]   Isthmic uterine fibroids: the dynamics of growth [J].
Duhan, Nirmala ;
Rajotia, Nidhi ;
Duhan, Urmila ;
Sangwan, Neetu ;
Gulati, Natasha ;
Sirohiwal, Daya .
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2009, 280 (02) :309-312
[9]   Low-dose mifepristone for uterine leiomyomata [J].
Eisinger, SH ;
Meldrum, S ;
Fiscella, K ;
le Roux, HD ;
Guzick, DS .
OBSTETRICS AND GYNECOLOGY, 2003, 101 (02) :243-250
[10]  
Funaki K, 2007, AM J OBSTET GYNECOL, V196